Clarivate

Clarivate Plc
Company type	Public
Industry	Analytics, Bibliometrics, Intellectual Property, Life Sciences, Business Intelligence
Predecessor	Thomson Reuters Intellectual Property and Science division
Founded	2016; 10 years ago
Headquarters	Philadelphia, United States / United Kingdom
Area served	Global
Key people	Jonathan Gear (CEO), Andrew Snyder (Chairman), Jerre Stead (Chairman Emeritus), Matti Shem Tov (incoming CEO)
Products	Web of Science, Publons, EndNote, Cortellis, DRG, CPA Global, Derwent, CompuMark, Darts-ip, ProQuest
Owner	Public shareholders
Website	clarivate.com

Clarivate Plc is a publicly listed analytics firm with British-American origins, providing subscription-based solutions in areas such as bibliometrics, scientometrics, business intelligence, market analysis, competitive intelligence for pharmaceutical and biotech sectors, patent management, regulatory adherence, trademark security, and domain and brand safeguarding. The company determines scientific journal impact factors utilizing data from its Web of Science suite, which also features Publons, EndNote, and EndNote Click. Additional product lines comprise Cortellis, DRG, CPA Global, Derwent, CompuMark, Darts-ip, alongside several offerings from ProQuest.

Established in 2016 following the acquisition of Thomson Reuters' Intellectual Property and Science division by Onex Corporation and Baring Private Equity Asia, Clarivate has grown through strategic acquisitions, including the notable purchase of ProQuest in 2021.

Company history

Clarivate's roots trace back to the Intellectual Property and Science segment of Thomson Reuters, formerly known as Thomson Scientific. In 2016, this division was divested by Thomson Reuters for $3.55 billion to private equity investors Onex Corporation and Baring Private Equity Asia, resulting in its emergence as an independent entity.

The company made its public debut in May 2019 via a merger with the special purpose acquisition company Churchill Capital Corp, subsequently listing on the New York Stock Exchange under the symbol NYSE:CLVT.

In response to the 2022 Russian invasion of Ukraine, Clarivate—maintaining an office in Odesa, Ukraine—announced on March 11, 2022, a complete halt to all commercial operations within Russia.

Operations

By 2023, Clarivate's organizational structure comprises three core business units: Intellectual Property Group, Life Sciences & Healthcare Group, and Academic and Government Group, each overseen by a dedicated president. The organization holds ISO/IEC 27001:2013 certification for information security management across these divisions.

The company has encountered criticism regarding monopolistic tendencies in the academic database sector, including raising prices on acquired assets, limited innovation and integration efforts for products, relocating jobs from the US and UK to India, and diminishing telephone support services for many inherited products.

Leadership Changes

On July 11, 2022, Jerre Stead stepped down from his roles as Executive Chair and CEO to become Non-Executive Chair. Jonathan Gear, previously CFO at IHS Markit, joined Clarivate as CEO-elect on the same day and officially took over as CEO on September 1, 2022.

Stead departed from the Board on October 20, 2022; Andrew Snyder—CEO of Cambridge Information Group and Clarivate's Vice Chairman—assumed the Chair position. Stead was honored with the title Chairman Emeritus. On August 6, 2024, Clarivate named Matti Shem Tov, former CEO of ProQuest, as its incoming CEO.

Acquisitions

June 1, 2017: Acquired Publons, a platform enabling researchers to receive credit for peer review contributions.
April 10, 2018: Purchased Kopernio, an AI-driven startup facilitating full-text access to scientific journal articles.
October 30, 2018: Integrated TrademarkVision, a provider of AI-powered trademark search technology.
September 9, 2019: Added SequenceBase, specializing in patent sequence data and search solutions for biotech, pharmaceutical, and chemical sectors.
December 2, 2019: Acquired Darts-ip, which supplies case law data and analytics tailored for intellectual property professionals.
January 17, 2020: Obtained Decision Resources Group (DRG), a healthcare research and consulting organization delivering industry insights.
June 22, 2020: Integrated CustomersFirst Now, focused on IP software and technology-enabled services.
October 1, 2020: Completed acquisition of CPA Global, recognized as a leader in IP software and tech-enabled services.
December 1, 2021: Finalized purchase of ProQuest, a provider of software, data analytics to academic and research institutions. The $5.3 billion acquisition from Cambridge Information Group was intended to merge ProQuest’s capabilities with Web of Science. Following the deal, ProQuest Chairman Andy Snyder became Clarivate’s vice chairman. The transaction underwent antitrust review by the Federal Trade Commission causing delays.
March 21, 2024: Acquired MotionHall, a Silicon Valley-based AI startup delivering industry-specific solutions for life sciences.
April 23, 2024: Added Global QMS, Inc., broadening the Life Sciences & Healthcare division into new markets.
July 22, 2024: Announced plans to acquire Rowan TELS to enhance support services for patent professionals.

Divestitures

In November 2020, Clarivate transferred ownership of its Techstreet unit to a commercial branch of the American Society of Mechanical Engineers.
In November 2022, Clarivate offloaded MarkMonitor to Newfold Digital. MarkMonitor provides domain registration and brand protection services to prominent corporations such as Google, Microsoft, Amazon, and Tencent.
In April 2024, Clarivate completed the divestment of Valipat.
On November 12, 2024, ScholarOne was sold by Clarivate to Silverchair.

ProQuest

Following its acquisition by Clarivate, ProQuest’s suite of products—including those from its prior acquisitions like Innovative Interfaces’ Vega, Sierra, Polaris, Millennium, and Virtua—is now managed under the Clarivate umbrella.

Cortellis

Cortellis delivers life sciences intelligence tools designed to aid decision-making throughout the development stages of drugs and medical devices. Its offerings include:

Cortellis Regulatory Intelligence
Cortellis Competitive Intelligence
Cortellis Clinical Trials Intelligence
Cortellis Deals Intelligence
Cortellis Drug Discovery Intelligence
Cortellis Digital Health Intelligence
MetaCore
Cortellis Generics Intelligence (previously Newport)
Chemistry, Manufacturing and Controls (CMC) Intelligence
BioWorld

Derwent

Clarivate supports patent research and intellectual property lifecycle management through products such as:

Derwent Innovation
Derwent SequenceBase
Derwent Data Analyzer
GENESEQ

CompuMark

Providing information services for brand and trademark experts to assess new trademarks and monitor existing ones against infringement, including:

SAEGIS®, an online trademark screening tool
TM go365, a self-service trademark research platform
Full Search, a comprehensive analyst-led trademark search service
Watching, a trademark protection monitoring service

ScholarOne

ScholarOne is a manuscript submission system that assists academic journal editors in managing submissions, recruiting peer reviewers, ensuring compliance with standards, and communicating with authors. This platform was sold to the American software firm Silverchair in 2024.

Highly Cited Researchers

Each year, Clarivate releases the Highly Cited Researchers list, which identifies the most influential scientists worldwide based on their production of multiple papers ranking in the top 1% by citations within their respective disciplines. Selection is based on outstanding performance across 21 fields defined by Clarivate Essential Science Indicators (ESI). The 2019 edition was published on November 19, 2019.

Clarivate Citation Laureates

Between 2002 and 2020, 59 individuals designated as Citation Laureates have gone on to win Nobel Prizes.

Top 100 Global Innovators Report

The yearly Top 100 Global Innovators report showcases organizations leading in innovation globally. It evaluates patented inventions with significant commercial potential, market impact, and influence on subsequent innovations. The report for 2020 was issued on February 19, 2020.

External links